2012 | | A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition | 김영배, 우현구 |
2013 | | A formulated red ginseng extract upregulates CHOP and increases TRAIL-mediated cytotoxicity in human hepatocellular carcinoma cells. | 김유선 |
2023 | | A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m6A Modification to Blood Biomarkers | 은정우, 정재연 |
2019 | | A Proposal for Modification of the Barcelona Clinic Liver Cancer Staging System Considering the Prognostic Implication of Performance Status | 김순선, 김진홍, 노충균, 신성재, 양민재, 유병무, 이광재, 이기명, 임선교, 정재연, 조효정, 황재철 |
2020 | | Abbreviated MRI with optional multiphasic CT as an alternative to full-sequence MRI: LI-RADS validation in a HCC-screening cohort | 김보현, 허지미 |
2023 | | Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma | 김봉완, 김순선, 은정우, 정재연, 조효정, 한지은 |
2013 | | Actionable gene expression-based patient stratification for molecular targeted therapy in hepatocellular carcinoma. | 왕희정 |
2004 | | Activin receptor-like kinase-7 induces apoptosis through activation of MAPKs in a Smad3-dependent mechanism in hepatoma cells. | 최경숙 |
2021 | | Added Value of CT Arterial Subtraction Images in Liver Imaging Reporting and Data System Treatment Response Categorization for Transcatheter Arterial Chemoembolization-Treated Hepatocellular Carcinoma | 권요한, 김재근, 김진우, 원제환, 이제희, 허지미 |
2007 | | Altered findings of hepatic arteriography after radiofrequency ablation of hepatocellular carcinoma: comparison of pre-ablation and post-ablation angiograms. | 원제환, 조재현 |
2006 | | An intracellular antibody can suppress tumorigenicity in hepatitis B virus X-expressing cells. | 권명희, 김경민, 박선, 신호준, 조혜성 |
2001 | | Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis. | 김영배 |
2015 | | AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma. | 왕희정 |
2014 | | Assessment of angiogenesis of hepatocellular carcinoma using dynamic contrast enhanced MR and histopathologic correlation in an experimental rat model. | 김영배, 김영철, 김재근, 김태희, 이제희 |
2013 | | Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection. | 정재연, 조성원 |
2014 | | Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma. | 정재연, 조성원 |
2012 | | Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients | 정재연, 조성원 |
2011 | | Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma | 우현구 |
2007 | | Bcl-xL blocks high dose doxorubicin-induced apoptosis but not low dose doxorubicin-induced cell death through mitotic catastrophe. | 최경숙 |
2016 | | Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy | 김봉완, 왕희정 |
2003 | | Bone scintigraphy of skeletal metastasis in hepatoma patients treated by TAE. | 윤준기 |
2010 | | Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study. | 김영철 |
2023 | | Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib | 김석휘, 김순선, 김영배, 은정우, 임수빈, 정재연, 조효정 |
2005 | | Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis. | 최경숙 |
2020 | | Characterizing Computed Tomography-Detected Arterial Hyperenhancing-Only Lesions in Patients at Risk of Hepatocellular Carcinoma: Can Non-Contrast Magnetic Resonance Imaging Be Used for Sequential Imaging? | 김보현, 허지미 |
2023 | | Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
2010 | | Claudin-1 acts through c-Abl-protein kinase Cdelta (PKCdelta) signaling and has a causal role in the acquisition of invasive capacity in human liver cells. | 윤계순 |
2013 | | Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. | 윤계순 |
2017 | | Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma | 왕희정 |
2017 | | Conditional Survival Analysis Demonstrates that Recurrence Risk of Surgically Treated Hepatocellular Carcinoma Evolves with Time | 김봉완, 왕희정 |
2022 | | Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes | 우현구 |
2017 | | CT features of hepatic metastases from hepatoid adenocarcinoma | 김혜진 |
2005 | | Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). | 최경숙 |
2011 | | Decreased lactate dehydrogenase B expression enhances claudin 1-mediated hepatoma cell invasiveness via mitochondrial defects | 김봉완, 박찬배, 왕희정, 윤계순 |
2013 | | Decreased mitochondrial OGG1 expression is linked to mitochondrial defects and delayed hepatoma cell growth. | 왕희정, 윤계순 |
2010 | | Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma. | 우현구 |
2016 | | Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up | 김봉완, 김순선, 김영배, 김재근, 양민재, 왕희정, 유병무, 이광재, 이제희, 정재연, 조성원, 조혜성, 조효정 |
2017 | | Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver | 강대용, 김보현, 김순선, 김재근, 신성재, 유병무, 이광재, 이기명, 이제희, 정재연, 조성원, 조효정 |
2016 | | Diagnostic Role of Blood Tumor Markers in Predicting Hepatocellular Carcinoma in Liver Cirrhosis Patients Undergoing Liver Transplantation | 김영환 |
2022 | | Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analysis Using the Korean Organ Transplantation Registry Database | 김봉완 |
2006 | | Direct activation of TGF-beta1 transcription by androgen and androgen receptor complex in Huh7 human hepatoma cells and its tumor in nude mice. | 윤계순, 임인경 |
2021 | | Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study | 김순선, 정재연 |
2012 | | Distal common bile duct metastasis from hepatocellular carcinoma | 김영철 |
2019 | | Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis | 권소미, 우현구, 윤사라, 지별아, 최지혜 |
2021 | | Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers | 김순선, 은정우, 정재연, 조효정 |
2019 | | Effect of Fibroblast Growth Factor-2 and its Receptor Gene Polymorphisms on the Survival of Patients With Hepatitis B Virus-associated Hepatocellular Carcinoma | 김순선, 노충균, 신성재, 은정우, 이기명, 정재연, 조효정 |
2014 | | Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis. | 김순선, 안선주, 임선교, 정재연, 조성원, 황재철 |
2023 | | Efficacy of Co-Medications in Patients with Alcoholic Liver Disease | 박래웅, 정재연 |
2023 | | Entecavir versus tenofovir on the recurrence of hepatitis B-related HCC after liver transplantation: A multicenter observational study | 김봉완 |
2018 | | EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma | 김봉완, 김순선, 김영배, 노진, 노충균, 양민재, 왕희정, 윤소영, 이길호, 정재연, 조성원, 조효정, 황재철 |
2010 | | Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma. | 왕희정 |
2023 | | Exosomal delivery of TRAIL and miR‑335 for the treatment of hepatocellular carcinoma (Review) | 최용준 |
2020 | | Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
2011 | | Exploring genomic profiles of hepatocellular carcinoma | 우현구 |
2024 | | Exploring the prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma | 조효정, 한지은 |
1997 | | Expression of androgen receptor and its implication in hepatoma cells. | 임인경, 조혜성 |
2001 | | Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases. | 왕희정, 조혜성 |
2004 | | Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta. | 최경숙 |
1998 | | Extensive analysis of duplicated-inverted hepatitis B virus integrations in human hepatocellular carcinoma. | 윤정구 |
2016 | | Genetic polymorphisms in the Wnt/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 노충균, 신성재, 유병무, 이광재, 이기명, 정재연, 조성원, 조효정 |